Giovanna Carrá

发表

Tumor Suppressors in Chronic Lymphocytic Leukemia: From Lost Partners to Active Targets

R. Taulli, M. Brancaccio, A. Morotti, 2020, Cancers.

The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase

R. Taulli, C. Panuzzo, G. Saglio, 2016, BMC Cancer.

N‐acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages

A. De Grassi, M. Mazzone, A. Menga, 2021, EMBO reports.

Understanding Aberrant Signaling to Elude Therapy Escape Mechanisms in Myeloproliferative Neoplasms

M. Brancaccio, A. Morotti, G. Carrà, 2022, Cancers.

Nuclear-cytoplasmic Shuttling in Chronic Myeloid Leukemia: Implications in Leukemia Maintenance and Therapy

I. Russo, A. Morotti, A. Guerrasio, 2019, Cells.

Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones

P. Pandolfi, R. Taulli, D. Torti, 2017, Oncotarget.

The Role of PTEN in Myeloid Malignancies

D. Torti, C. Panuzzo, G. Saglio, 2015, Hematology reports.

HAUSP compartmentalization in chronic myeloid leukemia

C. Panuzzo, G. Saglio, A. Morotti, 2015, European journal of haematology.

BCR-ABL inactivates cytosolic PTEN through Casein Kinase II mediated tail phosphorylation

P. Pandolfi, C. Panuzzo, G. Saglio, 2015, Cell cycle.

Modeling myeloproliferative neoplasms: From mutations to mouse models and back again.

G. Saglio, M. Brancaccio, A. Morotti, 2017, Blood reviews.

Inhibition of bromodomain and extra‐terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemia

P. Circosta, R. Taulli, G. Saglio, 2019, Journal of cellular and molecular medicine.

UMG Lenti: Novel Lentiviral Vectors for Efficient Transgene- and Reporter Gene Expression in Human Early Hematopoietic Progenitors

T. Mega, G. Morrone, E. Chiarella, 2014, PloS one.

The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias

R. Taulli, D. Torti, D. Cilloni, 2016, Oncotarget.

Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion

M. Papotti, R. Taulli, D. Torti, 2015, Oncotarget.

IκBα targeting promotes oxidative stress-dependent cell death

S. Novello, R. Taulli, C. Riganti, 2021, Journal of experimental & clinical cancer research : CR.

Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma.

M. Ladanyi, T. Tuschl, P. Provero, 2016, Cancer research.

Shedding Light on NF-κB Functions in Cellular Organelles

L. Avalle, M. Brancaccio, A. Morotti, 2022, Frontiers in Cell and Developmental Biology.

Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells

A. Morotti, G. Carrà, B. Maffeo, 2019, Blood and lymphatic cancer : targets and therapy.

The p53 orbit in chronic myeloid leukemia: time to move to patient care

A. Morotti, G. Carrà, S. Crivellaro, 2016 .

The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia

P. Circosta, D. Cilloni, G. Saglio, 2020, bioRxiv.

New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia

D. Torti, C. Panuzzo, G. Saglio, 2015, Oncoscience.

Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia

M. Brancaccio, A. Morotti, G. Carrà, 2018, Molecular Cancer.

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias

R. Taulli, C. Panuzzo, G. Saglio, 2015, Advances in hematology.

Clonal hematopoiesis by DNMT3A mutations as a common finding in idiopathic splanchnic vein thrombosis

D. Cilloni, E. Giugliano, R. Piazza, 2022, Haematologica.

P53 vs NF-κB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa

R. Taulli, A. Morotti, M. F. Lingua, 2020, Cellular and Molecular Life Sciences.

Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity

V. Poli, E. Hirsch, L. Conti, 2021, Cancer Research.

Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding

D. Weissman, Dan Liu, C. Desmedt, 2023, Science advances.

Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia

M. Brancaccio, A. Morotti, S. Rocca, 2018, Molecular Cancer.

Morgana acts as an oncosuppressor in chronic myeloid leukemia.

P. Pandolfi, M. Papotti, L. Silengo, 2015, Blood.

Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis

I. Russo, M. De Gobbi, A. Morotti, 2023, International journal of molecular sciences.

A Novel Multiplex qRT-PCR Assay to Detect SARS-CoV-2 Infection: High Sensitivity and Increased Testing Capacity

S. Petrillo, F. Altruda, P. Bottino, 2020, Microorganisms.

Non-Coding RNAs: The “Dark Side Matter” of the CLL Universe

A. Morotti, M. F. Lingua, B. Maffeo, 2021, Pharmaceuticals.

Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex

R. Taulli, G. Saglio, A. Morotti, 2016, International journal of molecular sciences.

-morgana haploinsufficiency causes in mice a lethal and transplantable CML like myeloid neoplasm -morgana is underexpressed in aCML and in a subgroup of CMLs where predicts a worse response

M. Papotti, L. Silengo, E. Hirsch, 2022 .

Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells

A. Morotti, B. Maffeo, A. Cartellà, 2019 .

IκB-α: At the crossroad between oncogenic and tumor-suppressive signals

C. Panuzzo, G. Saglio, A. Morotti, 2016, Oncology letters.

: the role of nuclear factor-kappa

R. Taulli, A. Morotti, M. F. Lingua, 2022 .